PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

lisdexamfetamine vs methylphenidate

Side-by-side comparison of lisdexamfetamine and methylphenidate Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
lisdexamfetamine CNS Stimulant
methylphenidate CNS Stimulant
Type
lisdexamfetamine Prescription
methylphenidate Prescription
Summary
lisdexamfetamine

Lisdexamfetamine (Vyvanse) is a stimulant medicine. It can help improve focus and reduce impulsive behavior.

methylphenidate

Methylphenidate extended-release capsules are a stimulant medicine. They are used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 to 12.

What It Treats
lisdexamfetamine

This medicine treats Attention Deficit Hyperactivity Disorder (ADHD) in adults and kids 6 years and older. It also treats moderate to severe binge eating disorder (BED) in adults. This medicine is not for weight loss.

methylphenidate

This medicine treats Attention Deficit Hyperactivity Disorder (ADHD) in children. ADHD can make it hard to focus, pay attention, and control impulsive behavior. This medicine can help improve focus and reduce hyperactivity.

How It Works
lisdexamfetamine

Lisdexamfetamine affects chemicals in your brain. These chemicals help control hyperactivity and impulses. It can also help reduce binge eating.

methylphenidate

Methylphenidate is a central nervous system (CNS) stimulant. It works by affecting chemicals in the brain that contribute to hyperactivity and impulsivity. The extended-release capsules release the medicine in two stages, providing both an immediate and a delayed effect.

Common Side Effects
lisdexamfetamine
  • Anorexia
  • Anxiety
  • Decreased appetite
  • Weight loss
  • Diarrhea
methylphenidate
  • Headache
  • Trouble sleeping (insomnia)
  • Upper abdominal pain
  • Decreased appetite
  • Loss of appetite (anorexia)
FAERS Reports
lisdexamfetamine
  • Taking too much medicine on purpose 1,068
  • Purposely hurting yourself 1,009
  • Medicine not working 904
  • Problem getting the medicine 487
  • Feeling tired 402
methylphenidate
  • No side effects 6,875
  • Using the medicine for a condition it is not approved for 5,881
  • Problem with the quality of the medicine 5,241
  • The medicine is not working 2,873
  • Mistake in giving the medicine 1,901
Serious Warnings
lisdexamfetamine

This medicine has a high risk for abuse, misuse, and addiction. Misusing it can lead to overdose and death. Your doctor will check your risk before and during treatment. Store this medicine safely and do not share it with anyone.

methylphenidate

This medicine has a high potential for abuse and dependence. Your doctor will assess your risk before prescribing it and monitor you during treatment. Misuse of this medicine may cause sudden death or serious heart problems.

Pregnancy
lisdexamfetamine

This medicine may harm your unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. Breastfeeding is not recommended while taking this medicine.

methylphenidate

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby. There is a pregnancy registry for women who take ADHD medicines during pregnancy.

Also Compare — Nearby Drugs

How to Read This lisdexamfetamine vs methylphenidate Comparison

lisdexamfetamine is classified in the CNS Stimulant drug class, while methylphenidate sits within the CNS Stimulant class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, lisdexamfetamine has 3,870 submissions while methylphenidate has 22,771. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between lisdexamfetamine and methylphenidate — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.